Table 2. Protein Regulations in FECD Tissuea.
accession no. | nameb | GOc | p-value | method | |
---|---|---|---|---|---|
Up-regulated Proteins | |||||
1 | O00468 | Agrin | E | 0.047, 0.001 | XIC, iTRAQ |
2 | P05090 | Apolipoprotein D | E | 0.045, 0.001 | XIC, iTRAQ |
3 | Q9Y240 | C-type lectin domain family 11 member A | E/I | 0.001 | iTRAQ |
4 | Q9NQ79 | Cartilage acidic protein 1 | E | 0.001 | iTRAQ |
5 | P10909 | Clusterin | E/I | 0.000 | iTRAQ |
6 | P12111 | Collagen alpha-3(VI) chain | E | 0.001 | iTRAQ |
7 | P01024 | Complement C3 | E | 0.016 | iTRAQ |
8 | P07585 | Decorin | E | 0.027 | iTRAQ |
9 | O95967 | EGF-containing fibulin-like extracellular matrix protein 2 | E | 0.044 | iTRAQ |
10 | Q9Y6C2 | EMILIN-1 | E | 0.022 | iTRAQ |
11 | P01876 | Ig alpha-1 chain C region | E | 0.010 | iTRAQ |
12 | O60938 | Keratocan | E | 0.027, 0.048 | XIC, iTRAQ |
13 | O15232 | Matrilin-3 | E | 0.011 | iTRAQ |
14 | Q15582 | Transforming growth factor-beta-induced protein ig-h3 | E | 0.015 | iTRAQ |
Down-regulated Proteins | |||||
1 | P02452 | Collagen alpha-1(I) chain | E | 0.003 | iTRAQ |
2 | P08123 | Collagen alpha-2(I) chain | E | 0.039 | iTRAQ |
3 | P02458 | Collagen alpha-1(II) chain | E | 0.009 | XIC |
4 | P02461 | Collagen alpha-1(III) chain | E | 0.02, 0.003 | XIC, iTRAQ |
5 | P53420 | Collagen alpha-4(IV) chain | E | 0.035 | XIC |
6 | P05997 | Collagen alpha-2(V) chain | E | 0.032 | iTRAQ |
7 | P35555 | Fibrillin-1 | E | 0.005, 0.021 | XIC, iTRAQ |
8 | P04264 | Keratin, type II cytoskeletal 1 | I | 0.006 | XIC |
9 | P35527 | Keratin, type I cytoskeletal 9 | I | 0.024 | XIC |
10 | P13645 | Keratin, type I cytoskeletal 10 | I | 0.031, 0.002 | XIC, iTRAQ |
11 | P14555 | Phospholipase A2, membrane associated | I | 0.004 | iTRAQ |
12 | P24821 | Tenascin | E | 0.047 | iTRAQ |
Proteins regulated with a p-value below 0.05 and quantified based on a minimum of 3 unique peptides.
Proteins in bold are within the most abundant proteins listed in Table 1.
Gene Ontology terms (GO) indicate whether the proteins are extracellularly (E) or intracellularly (I).